Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markert

Showing results (201-210 of 268) with videos related to

Pageof 27
Sort By:
Neurosurgery|May 30, 2014
Comparison of plan quality and delivery time between volumetric arc therapy (RapidArc) and Gamma Knife radiosurgery for multiple cranial metastasesEvan M Thomas, Richard A Popple, Xingen Wu, et al.
Cancer Gene Therapy|April 14, 2009
CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental gliomaL N Kaliberova, V Krendelchtchikova, D K Harmon, et al.
The American Journal of Physiology|April 13, 1999
Hypoxic contraction of small pulmonary arteries from normal and endotoxemic rats: fundamental role of NOS Terraz, F Baechtold, D Renard, et al.
Translational Oncology|October 19, 2016
Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of RhabdomyosarcomaAlicia M Waters, Laura L Stafman, Evan F Garner, et al.
Practical Radiation Oncology|February 26, 2021
Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance ResultsRichard A Popple, Matthew H Brown, Evan M Thomas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2019
Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical modelsBenjamin B Kasten, Ke Jiang, Denzel Cole, et al.
Gene Therapy|June 14, 2000
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trialJ M Markert, M D Medlock, S D Rabkin, et al.
Physiological Genomics|February 13, 2001
Differential gene expression profiling in human brain tumorsJ M Markert, C M Fuller, G Y Gillespie, et al.
Neuro-Oncology|July 19, 2015
Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex virusesGregory K Friedman, Blake P Moore, Li Nan, et al.
Theranostics|August 15, 2019
Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-OncologyBenjamin B Kasten, Neha Udayakumar, Jianmei W Leavenworth, et al.
Pageof 27

Showing results (201-210 of 268) with videos related to

Sort By:
Pageof 27
Neurosurgery|May 30, 2014
Comparison of plan quality and delivery time between volumetric arc therapy (RapidArc) and Gamma Knife radiosurgery for multiple cranial metastasesEvan M Thomas, Richard A Popple, Xingen Wu, et al.
Cancer Gene Therapy|April 14, 2009
CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental gliomaL N Kaliberova, V Krendelchtchikova, D K Harmon, et al.
The American Journal of Physiology|April 13, 1999
Hypoxic contraction of small pulmonary arteries from normal and endotoxemic rats: fundamental role of NOS Terraz, F Baechtold, D Renard, et al.
Translational Oncology|October 19, 2016
Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of RhabdomyosarcomaAlicia M Waters, Laura L Stafman, Evan F Garner, et al.
Practical Radiation Oncology|February 26, 2021
Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance ResultsRichard A Popple, Matthew H Brown, Evan M Thomas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2019
Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical modelsBenjamin B Kasten, Ke Jiang, Denzel Cole, et al.
Gene Therapy|June 14, 2000
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trialJ M Markert, M D Medlock, S D Rabkin, et al.
Physiological Genomics|February 13, 2001
Differential gene expression profiling in human brain tumorsJ M Markert, C M Fuller, G Y Gillespie, et al.
Neuro-Oncology|July 19, 2015
Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex virusesGregory K Friedman, Blake P Moore, Li Nan, et al.
Theranostics|August 15, 2019
Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-OncologyBenjamin B Kasten, Neha Udayakumar, Jianmei W Leavenworth, et al.
Pageof 27